文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新冠疫情:改善临床试验的催化剂。

The COVID-19 pandemic: a catalyst to improve clinical trials.

机构信息

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Nat Rev Cardiol. 2020 Nov;17(11):673-675. doi: 10.1038/s41569-020-00439-7.


DOI:10.1038/s41569-020-00439-7
PMID:32873977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7461742/
Abstract

The COVID-19 pandemic has provided the vital stepping stones to improve how clinical trials are conducted. We provide an overview of the major changes to the clinical trial process instigated by the pandemic and suggest ways to make these changes sustainable.

摘要

COVID-19 大流行提供了重要的垫脚石,以改善临床试验的进行方式。我们概述了大流行引发的临床试验流程的主要变化,并提出了使这些变化可持续的方法。

相似文献

[1]
The COVID-19 pandemic: a catalyst to improve clinical trials.

Nat Rev Cardiol. 2020-11

[2]
[Ethics of clinical trials].

Med Sci (Paris). 2020-4

[3]
Single-Institution Experience in Clinical Trials During the COVID-19 Pandemic in Spain: Not So Bad After All?

JCO Glob Oncol. 2020-6

[4]
Digitalized Adaptation of Oncology Trials during and after COVID-19.

Cancer Cell. 2020-8-10

[5]
Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.

JACC Heart Fail. 2020-5

[6]
Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy.

ESMO Open. 2020-4

[7]
Virtual consent for virtual patients: benefits of implementation in a peri- and post-COVID-19 era.

Br J Hosp Med (Lond). 2020-7-2

[8]
Pandemic could add noise to clinical trial data.

Science. 2020-5-15

[9]
Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.

N Engl J Med. 2020-10-8

[10]
A rationale and framework for seeking remote electronic or phone consent approval in endovascular stroke trials - special relevance in the COVID-19 environment and beyond.

J Neurointerv Surg. 2020-5-7

引用本文的文献

[1]
Quantitative Assessment of a Novel Device Designed for Patient-centric Sampling of Dried Plasma Using Targeted Proteomics.

Anal Chem. 2025-7-1

[2]
Using mHealth to support health coaching for patients with hypertension: A case-control study.

Digit Health. 2025-4-21

[3]
Improving Participant Recruitment in Clinical Trials: Comparative Analysis of Innovative Digital Platforms.

J Med Internet Res. 2024-12-18

[4]
Leveraging Decentralized Clinical Trial Management Systems (dCTMS) to Advance Science: Exploring Challenges Related to the Diffusion of Innovation and Its Execution.

Blockchain Healthc Today. 2024-4-30

[5]
Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.

Healthcare (Basel). 2024-2-23

[6]
Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness.

Innov Clin Neurosci. 2023-9-1

[7]
Leveraging Every Door Direct Mail for remote recruitment of a rural Appalachian study Sample: Response rate and representativeness.

Prev Med Rep. 2023-1-25

[8]
Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot.

Blockchain Healthc Today. 2021-10-15

[9]
Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People With Knee Osteoarthritis.

Arthritis Care Res (Hoboken). 2023-9

[10]
Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis.

J Mark Access Health Policy. 2022-8-9

本文引用的文献

[1]
The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.

J Am Heart Assoc. 2020-9-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索